Predicting patients at high-risk of systemic reactions to cluster allergen immunotherapy: A pilot prospective observational study

Journal of Investigational Allergology and Clinical Immunology

Volumn 17, Issue 6, 2007, Pages 386-392

  Justicia, J L ^a,b   Barasona, M J ^a   Serrano, Pilar ^a   Moreno, C ^a   Guerra, F ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b NONE

Author keywords

Adverse reactions; Allergen immunotherapy; Asthma; Pollen; Predictive clinical model; Rhinitis

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; POLLEN ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALLERGIC REACTION; ARTICLE; CHENOPODIUM ALBUM; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; FEMALE; GRASS POLLEN; HABITAT; HIGH RISK PATIENT; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; OLIVE; PRICK TEST; PROGNOSIS; RESIDENTIAL HOME; RESPIRATORY TRACT ALLERGY; SCHOOL CHILD; SEASONAL VARIATION; SEX DIFFERENCE; SKIN TEST;

ADOLESCENT; ADULT; CHILD; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; MALE; ODDS RATIO; PILOT PROJECTS; PROSPECTIVE STUDIES; RISK; ROC CURVE;

EID: 36849093827     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Frew AJ, Norman PS, Golden DB, Adelman D. Inmunoterapia. In: Holgate ST, Church MK, Lichtenstein LM, editors. Alergia. 2nd ed. Madrid: Ediciones Harcourt; 2002. p. 175-85.
2. Malling HJ. Immunotherapy as an effective tool in allergy treatment. Allergy. 1998;53:461-72.
3. Calderón MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database of Systematic Reviews 2007, Issue 1. Art No.: CD001936. DOI: 10.1002/14651858.CD001936.pub2.
4. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD001186. DOI: 10.1002/14651858.CD001186.
5. More DR, Hagan LL. Factors affecting compliance with allergen immunotherapy at a military medical center. Ann Allergy Asthma Immunol. 2002;88:391-4.
6. Parmiani S, Fernández-Távora L, Moreno C, Guardia P, Rico P. Clustered schedules in allergen-specific immunotherapy. Allergol Immunopathol (Madr). 2002;30:283-91.
7. Cox L. Accelerated immunotherapy schedules: review of efficacy and safety. Ann Allergy Asthma Immunol. 2006;97:126-38.
8. Malling HJ, Weeke B. Immunotherapy. Position Paper of the EAACI. Allergy. 1993;48 (suppl 14):9-35.
9. Álvarez-Cuesta E, Bousquet J, Canonica GW, Durham SR, Malling HJ, Valovirta E. Standars for practical allergen-specific immunotherapy. Allergy. 2006;61(Suppl. 82):1-20.
10. Cook PR, Farias C. The safety of allergen immunotherapy: a literature review. Ear Nose Throat J. 1998;378-88.
11. Malling HJ. Minimising the risks of allergen-specific injection immunotherapy. Drug Saf. 2000;23:32.
12. Tabar AI, Lizaso MT, Garcia BE, Echechipia S, Olaguibel JM, Rodriguez A. Tolerance of immunotherapy with a standardized extract of Alternaria tenuis in patients with rhinitis and bronchial asthma. J Investig Allergol Clin Immunol. 2000;10:327-33.
13. Hejjaoui A, Dhivert H, Michel FB, Bousquet J. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract: IV. Systemic reactions according to the immunotherapy schedule. J Allergy Clin Immunol. 1990;85:473-9.
14. Bernstein DI, Wanner M, Borish L, Liss GM. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol. 2004;113:1129-36.
15. Amin HS, Liss GM, Bernstein DI. Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Clin Immunol. 2006;117:169-75.
16. Golden DB, Kwiterovich KA, Kagey-Sobotka A, Valentine MD, Lichtenstein LM. Discontinuing venom immunotherapy: outcome after five years. J Allergy Clin Immunol. 1996;97:579-87.
17. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, Till SJ, Hamid QA, Nouri-Aria KT. Long-term clinical efficacy of grass-pollen immunotherapy. N Eng J Med. 1999;341:468-75.
18. Pauli G. Evolution in the understanding of cross-reactivities of respiratory allergens: the role of recombinant allergens. Int Arch Allergy Immunol. 2000;123:183-95.
19. McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiell IG, Richardson WS. Users' guides to the medical literature. XXII: How to use articles about clinical decision rules. JAMA. 2000;284:79-84.
20. Mellerup MT, Hahn GW, Poulsen LK, Malling H. Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment. Clin Exp Allergy. 2000;30:1423-9.
21. Ragusa FV, Passalacqua G, Gambardella R, Campanari S, Barbieri MM, Scordamaglia A, Canonica GW. Nonfatal systemic reactions to subcutaneous immunotherapy: a 10-year experience. J Investig Allergol Clin Immunol. 1997;7:151-4.
22. Gastaminza G, Algorta J, Audicana M, Etxenagusia M, Fernandez E, Muñoz D. Systemic reactions to immunotherapy: influence of composition and manufacturer. Clin Exp Allergy. 2003;33:470-4.